ira shoulson on r & d board of prana biotech

Has anyone noticed from the new website that Ira Shoulson was added to Prana's R & D advisory board. I personally think this is great news.

On page 49 of the most recent 20F (10/23/2013) it becomes apparent that he has replaced Prof Jean-Marc Orgogozo, M.D. since it's publication.

Ira Shoulson founded both the Parkinson's Study Group and Huntington's Study Group in 1984/1985 timeframe. He is the one that approached Prana Biotech to test PBT2 for Huntington's Disease that resulted in the REACH2HD trial.

I think this is huge to have his involvement in an advisory capacity for both the advancement of PBT2 and potentially PBT434. Please go read his bio on the new website, under About Us

Welcome to the Huntington Study Group web site. The HSG consists of clinical researchers world-wide, who care for HD patients and families and who are working diligent to combat the disease. Several new research trials are underway or being launched. We ask you to visit our website for regular updates. We greatly appreciate your time and interest in seeking treatments that make a difference for Huntington disease.

Sincerely yours,

Ira Shoulson, MD, Chair HSG Executive Committee

Steven Hersch, MD, PhD, Co-chair HSG Executive Committee